does glp 1 cause birth defects Increased Risk of NICU Stays for Babies Born to Mothers Prescribed GLP-1 Medications in the 90 Days Before Pregnancy Study links GLP-1 use to
Description
Novo Nordisks oral Wegovy, approved in December 2025, was the first oral GLP-1 to hit the obesity market
PLoS One, 13 ,
This can result in erratic blood sugar levels, causing both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar)
Studies show that 40 to 85 percent of people taking standard doses of GLP-1s have side effects, most often gastrointestinal troubles like nausea and vomiting
Genetics should not replace provider judgment, but it can help inform a more personalized plan
